Assessment of Pulmonary Functions and Peripheral Muscle Strength of COPD Patients in Different GOLD Stages
Launched by MARMARA UNIVERSITY · Mar 16, 2021
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
Chronic obstructive pulmonary disease (COPD) is a common disease characterized by airway obstruction against harmful particles and gases in the airway and lungs, and is progressive, treatable and preventable.
The severity of the disease in COPD is determined according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines (2). While determining the severity of airway obstruction with the patient's spirometric values in COPD; Combined COPD assessment is made with symptomatic evaluation, number of exacerbations and hospitalizations. Airway restriction is numerically ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being in COPD stable period and over the age of 40,
- • The absence of abnormal laboratory findings,
- • Not having a mental problem that prevents filling the questionnaires to be used in the study, - The absence of any other respiratory disease such as asthma,
- • Giving the informed consent.
- Exclusion Criteria:
- • COPD exacerbation (hospitalization with acute exacerbation in the last 15 days),
- • Presence of cognitive impairment,
- • Pregnancy status,
- • Ischemic heart disease,
- • Kyphoscoliosis and advanced postural disorder,
- • Orthopedic problems and amputation surgery,
- • Emphysema, bullous lung disease,
- • Presence of bronchiectasis,
- • Previous thoracic surgery history,
- • Presence of lung cancer,
- • Advanced heart failure.
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Maltepe, Turkey
Patients applied
Trial Officials
Begum Unlu, PT, MSc
Principal Investigator
Marmara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials